Regulation of antigen processing and presentation molecules in West Nile virus-infected human skin fibroblasts

Virology

Volumn 324, Issue 2, 2004, Pages 286-296

  Arnold, Stephanie J ^a   Osvath, Sarah R ^a   Hall, Roy A ^b   King, Nicholas J C ^a   Sedger, Lisa M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

E; envelope; Flavivirus; HLA; Human leukocyte antigen A, B, C; Immune recognition molecules; Interferon; Low molecular weight polypeptide; Transporter associated with antigen presentation; Tumor necrosis factor ; West Nile virus

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; MESSENGER RNA;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; SURFACE PROPERTY; WEST NILE FLAVIVIRUS;

ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ATP-BINDING CASSETTE TRANSPORTERS; CYSTEINE ENDOPEPTIDASES; FIBROBLASTS; FLUORESCEINS; FLUORESCENT ANTIBODY TECHNIQUE; HLA ANTIGENS; HLA-A ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; TUMOR NECROSIS FACTOR-ALPHA; VIRAL NONSTRUCTURAL PROTEINS; WEST NILE FEVER; WEST NILE VIRUS;

ACARI; FLAVIVIRUS; WEST NILE VIRUS;

EID: 2942744773     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.03.036     Document Type: Article

References (42)

1. Barnstable C.J., Bodmer W.J., Brown G., Galfre G., Milstein C., Williams A.F., Zeigler A. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens - New tools for genetic analysis. Cell. 14:1978;9-20
2. Buckley A., Dawson A., Moss S.R., Hinsley S.A., Bellamy P.E., Gould E.A. Serological evidence of West Nile virus, Usutu virus and Sindbis virus infection of birds in the UK. J. Gen. Virol. 84:2003;2807-2817
3. CDC update. West Nile virus activity - United States, October 3-9, 2002. Morb. Mort. Wkly. Rep. vol. 51:2002;903
4. Chatterjee-Kishore M., Wright K.L., Ting J.P., Stark G.R. How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J. 19:2000;4111-4122
5. Coia G., Parker M.D., Speight G., Byrne M.E., Westaway E.G. Nucleotide and complete amino acid sequences of Kunjin virus: definitive gene order and characteristics of the virus-specified proteins. J. Gen. Virol. 69:1988;1-21
6. Crook P.D., Crowcroft N.S., Brown D.W. West Nile virus and the threat to the UK. Commun. Dis. Public Health. 5:2002;138-143
7. Diamond M.S. Evasion of innate and adaptive immunity by flaviviruses. Immunol. Cell Biol. 81:2003;196-206
8. Douglas M.W., Kesson A.M., King N.J. CTL recognition of West Nile virus-infected fibroblasts is cell cycle dependent and is associated with virus-induced increases in class I MHC antigen expression. Immunology. 82:1994;561-570
9. Georgopoulos N.T., Proffitt J.L., Blair G.E. Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene. 19:2000;4930-4935
10. Hall R.A., Nisbet D.J., Pham K.B., Pyke A.T., Smith G.A., Khromykh A.A. DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus. Proc. Natl. Acad. Sci. U.S.A. 100:2003;10460-10464
11. Harlow E., Lane D. Antibodies. A Laboratory Manual. 1988;Cold Stream Harbor Laboratory, Cold Stream Harbor, New York
12. Heyninck K., Beyaert R. Crosstalk between NF-kappaB-activating and apoptosis-inducing proteins of the TNF-receptor complex. Mol. Cell. Biol. Res. Commun. 4:2001;259-265
13. Johnson D.R. Different expression of Human major histocompatibility class I loci: HLA-A, -B, and -C. Hum. Immunol. 61:2000;389-396
14. Kayagaki N., Yamaguchi N., Nagao F., Matsuo S., Maeda H., Okumura K., Yagita H. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. U.S.A. 94:1997;3914-3919
15. Kesson A.M., King N.J. Transcriptional regulation of major histocompatibility complex class I by flavivirus West Nile is dependent on NF-kappaB activation. J. Infect. Dis. 184:2001;947-954
16. Kesson A.M., Cheng Y., King N.J. Regulation of immune recognition molecules by flavivirus, West Nile. Viral Immunol. 15:2002;273-283
17. King N.J., Kesson A.M. Interferon-independent increases in class I major histocompatibility complex antigen expression follow flavivirus infection. J. Gen. Virol. 69:1988;2535-2543
18. King N.J., Kesson A.M. Interaction of flaviviruses with cells of the vertebrate host and decoy of the immune response. Immunol. Cell Biol. 81:2003;207-216
19. King N.J., Maxwell L.E., Kesson A.M. Induction of class I major histocompatibility complex antigen expression by West Nile virus on gamma interferon-refractory early murine trophoblast cells. Proc. Natl. Acad. Sci. U.S.A. 86:1989;911-915
20. Kurane I., Janus J., Ennis F.A. Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF. Arch. Virol. 124:1992;21-30
21. Lobigs M., Blanden R.V., Mullbacher A. Flavivirus-induced up-regulation of MHC class I antigens; implications for the induction of CD8+ T-cell-mediated autoimmunity. Immunol. Rev. 152:1996;5-19
22. Lobigs M., Mullbacher A., Regner M. MHC class I up-regulation by flaviviruses: immune interaction with unknown advantage to host or pathogen. Immunol. Cell Biol. 81:2003;217-223
23. Min W., Pober J.S., Johnson D.R. Interferon induction of TAP1: the phosphatase SHP1 regulates crossover between the IFN-alpha/beta and the IFN-gamma signal-transduction pathways. Circ. Res. 83:1998;815-823
24. Momburg F., Mullbacher A., Lobigs M. Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by flavivirus infection. J. Virol. 75:2001;5663-5671
25. Monath T.P., Heinz F.X. Flavivurus. Fields B.N., Knipe D.M., Howley P.M. Virology. 1996;961-1034 Lippincott-Raven, Philadelphia
26. Murgue B., Murri S., Triki H., Deubel V., Zeller H.G. West Nile in the Mediterranean basin: 1950-2000. Ann. N.Y. Acad. Sci. 951:2001;117-126
27. Murgue B., Zeller H., Deubel V. The ecology and epidemiology of West Nile Virus in Africa, Europe and Asia. Curr. Top. Microbiol. Immunol. 267:2002;195-221
28. O'Leary D.R., Nasci R.S., Campbell G.L., Marfin A.A. West Nile virus activity - United Stated, 2001. Morb. Mort. Wkly. Rep. 51:2002;496-501
29. Pletnev A.G., Putnak R., Speicher J., Wagar E.J., Vaughn D.W. West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proc. Natl. Acad. Sci. U.S.A. 99:2002;3036-3041
30. Proffitt J.A., Blair G.E. The MHC-encoded TAP1/LMP2 bidirectional promoter is down-regulated in highly oncogenic adenovirus type 12 transformed cells. FEBS Lett. 400:1997;141-144
31. Proffitt J.L., Sharma E., Blair G.E. Adenovirus 12-mediated down-regulation of the major histocompatibility complex (MHC) class I promoter: identification of a negative regulatory element responsive to Ad12 E1A. Nucleic Acids Res. 22:1994;4779-4788
32. ProMed-mail, 2003. West Nile virus update, 2003. ProMed-mail. http://www.promedmail.org (Archive Number 20030905.2227), 5 Sept, 2003.
33. Rice C.M. Flaviviridae: the viruses and their replication. Fields B.N., Knipe D.M., Howley P.M. Virology. 1996;931-959 Lippincott-Raven, Philadelphia
34. Ruby J., Bluethmann H., Peschon J.J. Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors. J. Exp. Med. 186:1997;1591-1596
35. Sedger L.M., Shows D.M., Blanton R.A., Peschon J.J., Goodwin R.G., Cosman D., Wiley S.R. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J. Immunol. 163:1999;920-926
36. Shen J., Devery J.M., King N.J. Early induction of interferon-independent virus-specific ICAM-1 (CD54) expression by flavivirus in quiescent but not proliferating fibroblasts - Implications for virus-host interactions. Virology. 208:1995;437-449
37. Shen J., T-To S.S., Schrieber L., King N.J.C. Early E-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines. J. Virol. 71:1997;9323-9932
38. WHO Disease outbreaks reported: West Nile virus in the United States - Update 6. Communicable Disease Surveillance and Response (CSR). World Health Organization. vol. 2002:2002;. http://www.who.int/csr/don/2002_10_30/en
39. Wong G.H., Goeddel D.V. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature. 323:1986;819-822
40. Wong G.H., Clark-Lewis I., McKimm-Breschkin L., Harris A.W., Schrader J.W. Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. J. Immunol. 131:1983;788-793
41. Wong G.H., Clark-Lewis I., Harris A.W., Schrader J.W. Effect of cloned interferon-gamma on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin. Eur. J. Immunol. 14:1984;52-56
42. Ziegler A., Uchanska-Ziegler B., Zeuthen J., Wernet P. HLA antigen expression at the single cell level on a K562 X B cell hybrid: an analysis with monoclonal antibodies using bacterial binding assays. Somatic Cell Genet. 8:1982;775-789